Hyperglycemia Impairs Skeletogenesis from Embryonic Stem Cells by Affecting Osteoblast and Osteoclast Differentiation
- 1 March 2011
- journal article
- research article
- Published by SAGE Publications in Stem Cells and Development
- Vol. 20 (3) , 465-474
Abstract
High maternal blood glucose levels caused by diabetes mellitus can irreversibly lead to maldevelopment of the growing fetus with specific effects on the skeleton. To date, it remains controversial at which stage embryonic development is affected. Specifically during embryonic bone development, it is unclear whether diminished bone mineral density is caused by reduced osteoblast or rather enhanced osteoclast function. Therefore, the aim of this study was to characterize the growth as well as the skeletal differentiation capability of pluripotent embryonic stem cells (ESCs), which may serve as an in vitro model for all stages of embryonic development, when cultured in diabetic levels of D-glucose (4.5 g/L) versus physiological levels (1.0 g/L). Results showed that cells cultivated in physiological glucose gave rise to a higher number of colonies with an undifferentiated character as compared to cells grown in diabetic glucose concentrations. In contrast, these cultures were characterized by slightly decreased expression of proteins associated with the stem cell state. Furthermore, differentiation of ESCs into osteoblasts and osteoclasts was favored in physiological glucose concentrations, demonstrated by an increased matrix calcification, enhanced expression of cell-type-specific mRNAs, as well as activity of the cell-type-specific enzymes, alkaline, and tartrate resistant acidic phosphatase. In fact, this pattern was noted in murine as well as in primate ESCs. Our study suggests that an interplay between both the osteoblast and the osteoclast lineage is needed for proper skeletal development to occur, which seems impaired in hyperglycemic conditions.Keywords
This publication has 45 references indexed in Scilit:
- Wnt Signaling Mediates Self-Organization and Axis Formation in Embryoid BodiesCell Stem Cell, 2008
- Osteoporosis among patients with type 1 and type 2 diabetesDiabetes & Metabolism, 2008
- Synergistic effect of high glucose and ANG II on proliferation of mouse embryonic stem cells: Involvement of PKC and MAPKs as well as AT1 receptorJournal of Cellular Physiology, 2007
- Dissecting the Molecular Hierarchy for Mesendoderm Differentiation Through a Combination of Embryonic Stem Cell Culture and RNA InterferenceStem Cells, 2007
- Elevated Pregnancy Losses at High and Low Extremes of Maternal Glucose in Early Normal and Diabetic PregnancyDiabetes Care, 2005
- Threshold values of maternal blood glucose in early diabetic pregnancy - prediction of fetal malformationsActa Obstetricia et Gynecologica Scandinavica, 2005
- Effects of diabetic pregnancy on the fetus and newbornSeminars in Perinatology, 2000
- Gestational DiabetesJournal of the American Pharmaceutical Association, 1998
- Diabetic bone diseaseCalcified Tissue International, 1991
- Decreased Bone Mineral Content in Infants of Diabetic MothersAmerican Journal of Perinatology, 1988